Rising Prevalence Of Viral Infections Propels Growth Of Viral Diagnostic Test Kits Market Driving Market Acceleration in the Viral Diagnostic Test Kits Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Viral Diagnostic Test Kits Market Size By 2025?
Recently, there has been a significant growth in the market size of viral diagnostic test kits. This market, valued at $16.26 billion in 2024, is expected to expand to $17.62 billion in 2025, showcasing a compound annual growth rate (CAGR) of 8.4%. The historical growth of this market has been driven by factors such as increased healthcare spending, surge in global travel, the prevalence of chronic viral infections, a boost in demand for at-home testing kits, and the expansion of personalized medicine.

How Big Is the Viral Diagnostic Test Kits Market Size Expected to Grow by 2029?
The market for viral diagnostic test kits is anticipated to witness robust expansion in the upcoming years, ballooning to a size of $23.99 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. The projected growth in this period may be due to factors like growing cases of Ebola virus, rising instances of hemorrhagic fever, an increase in the number of viral infections, heightened occurrences of respiratory syncytial virus, and a surge in hepatitis cases. Key trends predicted to shape the market during the forecast period involve technological progress, point-of-care testing, utilization of AI and data analytics, incorporation with digital health records, and the use of next-generation sequencing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

Which Key Market Drivers Powering Viral Diagnostic Test Kits Market Expansion and Growth?
The increasing incidence of viral infections is anticipated to boost the expansion of the viral diagnostic test kits market in the future. Viral infections occur when tiny viruses infiltrate host cells, produce more of their kind within those cells, and trigger a wide array of symptoms that can vary from mild to severe and affect various body regions. Factors such as international travel, urbanization, changes in the climate impacting vector-borne diseases, and the emergence of new viral variants that could instigate novel outbreaks or spread to uncharted territories, contribute to the escalating rate of viral infections. Viral diagnostic test kits play a crucial role in distinguishing and verifying the existence of specific viral infections in patients by identifying viral nucleic acids (RNA or DNA), antigens, or antibodies in biological specimens like blood, saliva, or nasal swabs. As an example, data from the Centers for Disease Control and Prevention (CDC), the public health agency in the US, show that in 2022, 2,126 new acute hepatitis B cases were documented, along with 16,729 newly reported chronic hepatitis B cases. During the same timeframe, 14 jurisdictions within the US reported acute hepatitis B rates exceeding the national average. Hence, the escalating incidence of viral infections propels the growth of the viral diagnostic test kits market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Viral Diagnostic Test Kits Market?
Leading firms in the viral diagnostic test kits market are introducing inventive products like virus detection kits to maintain their prominence in the market. The virus detection kit is a diagnostic implement designed to detect the presence of specific viruses in biological specimens, offering precise and swift results for effective disease tracking and control. For example, in August 2024, BlueStain Global Ltd, a UK-based firm, introduced their MPox virus detection kit. This Bluestain MPox virus detection kit is a quick diagnostic test constructed to detect the mpox virus rapidly and accurately, providing results in only 15 to 30 minutes. This novel kit aims to improve public health interventions by enabling early detection and control of mpox outbreaks, especially in regions with limited resources.

What Are the Emerging Segments in the Viral Diagnostic Test Kits Market?
The viral diagnostic test kits market covered in this report is segmented -

1) By Test: Traditional Tests, Rapid Test
2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users

Subsegments:
1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing
2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16821&type=smp

Who Are the Global Leaders in the Viral Diagnostic Test Kits Market?
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

Which are the Top Profitable Regional Markets for the Viral Diagnostic Test Kits Industry?
North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.